Kellogg Eye Center
Ocular surgeries are steadily shifting away from hospitals, a move that offers convenience and financial perks. But questions of safety and accessibility remain.
Seeing double is a fairly common issue — that can be serious. That’s why both eye specialists and primary care providers should be prepared to address it.
An analysis of Medicare Part D data reveals that a preference among eye care providers for name-brand medication has systemwide cost implications.
A newly approved stent designed to treat glaucoma is a new option for some patients at U-M’s Kellogg Eye Center, one of the first centers in the country to offer it.
Ophthalmologists urge providers to stop prescribing antibiotics for a common eye condition that typically clears up without medication.